Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
International Centre for Diarrhoeal Disease Research, Bangladesh
General objective: 1. To evaluate the safety of EV71 vaccine in adults and in children age 6-71 months 2. To evaluate the immunogenicity of the vaccine in children by assessing the neutralization antibody levels before immunization; then 7, 15, 30 days after the first inoculation; and also 7, 15, 30 days after the second inoculation. 3. To assess the incidence rate of adverse reactions/events Specific objective: To find out: 1. Seroconversion rate of neutralization antibody on the day 30 after the whole-range immunization (i.e. after 2nd dose of vaccination); 2. Positive rate and Geometric Mean Titer of neutralization antibody on the day 30 after the whole-range immunization; 3. Seroconversion rate, positive rate and Geometric Mean Titer of serum neutralization antibody on the day 7, day 15, day 30 after the first inoculation; 4. Seroconversion rate,positive rate and Geometric Mean Titer of serum neutralization antibody on the day 7, day 15 after the second inoculation; 5. The incidence rate of adverse reactions \& serious adverse events during the observation period of safety; 6. The incidence rate of adverse reactions 0-30 days after each inoculation of vaccine; 7. The incidence rate of adverse events 0-7 days after each inoculation of vaccine;
Age
0–45
Sex
ALL
Healthy volunteers
Accepted
